RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Valerie Odero-Marah to HMGA2 Protein

This is a "connection" page, showing publications Valerie Odero-Marah has written about HMGA2 Protein.
Connection Strength

2.383
  1. Hwang BJ, Akinniyi O, Harrison S, Gibbs D, Waihenya C, Gachii A, Dike PE, Elliott B, Khalifa F, Ragin C, Odero-Marah V. AI/ML-Assisted Detection of HMGA2 RNA Isoforms in Prostate Cancer Patient Tissue. Int J Mol Sci. 2025 Dec 24; 27(1).
    View in: PubMed
    Score: 0.944
  2. Dike PE, Hwang BJ, Campbell T, Awolowo M, Elliott B, Odero-Marah V. HMGA2 regulates GPX4 expression and ferroptosis in prostate cancer cells. Biochem Biophys Res Commun. 2024 12 03; 736:150859.
    View in: PubMed
    Score: 0.870
  3. Hawsawi O, Henderson V, Burton LJ, Dougan J, Nagappan P, Odero-Marah V. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer. Biochem Biophys Res Commun. 2018 09 26; 504(1):196-202.
    View in: PubMed
    Score: 0.569
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support